Overexpressed HSP family genes have been reported to promote cancer growth and metastasis in several tumors, implying that HSP family genes are potential therapeutic targets for NACT-ESCC [18, 19]. Here, HSP90B2P is linked to esophageal squamous cell carcinoma.